1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cytomegalovirus Disease Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Ganciclovir 1.2.3 Valganciclovir 1.2.4 Foscarnet 1.2.5 Cidofovir 1.2.6 Others 1.3 Market by Application 1.3.1 Global Cytomegalovirus Disease Treatments Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Stem Cell Transplantation 1.3.3 Organ Transplantation 1.3.4 Congenital CMV Infection 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cytomegalovirus Disease Treatments Market Perspective (2016-2027) 2.2 Cytomegalovirus Disease Treatments Growth Trends by Regions 2.2.1 Cytomegalovirus Disease Treatments Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cytomegalovirus Disease Treatments Historic Market Share by Regions (2016-2021) 2.2.3 Cytomegalovirus Disease Treatments Forecasted Market Size by Regions (2022-2027) 2.3 Cytomegalovirus Disease Treatments Industry Dynamic 2.3.1 Cytomegalovirus Disease Treatments Market Trends 2.3.2 Cytomegalovirus Disease Treatments Market Drivers 2.3.3 Cytomegalovirus Disease Treatments Market Challenges 2.3.4 Cytomegalovirus Disease Treatments Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cytomegalovirus Disease Treatments Players by Revenue 3.1.1 Global Top Cytomegalovirus Disease Treatments Players by Revenue (2016-2021) 3.1.2 Global Cytomegalovirus Disease Treatments Revenue Market Share by Players (2016-2021) 3.2 Global Cytomegalovirus Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cytomegalovirus Disease Treatments Revenue 3.4 Global Cytomegalovirus Disease Treatments Market Concentration Ratio 3.4.1 Global Cytomegalovirus Disease Treatments Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus Disease Treatments Revenue in 2020 3.5 Cytomegalovirus Disease Treatments Key Players Head office and Area Served 3.6 Key Players Cytomegalovirus Disease Treatments Product Solution and Service 3.7 Date of Enter into Cytomegalovirus Disease Treatments Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cytomegalovirus Disease Treatments Breakdown Data by Type 4.1 Global Cytomegalovirus Disease Treatments Historic Market Size by Type (2016-2021) 4.2 Global Cytomegalovirus Disease Treatments Forecasted Market Size by Type (2022-2027) 5 Cytomegalovirus Disease Treatments Breakdown Data by Application 5.1 Global Cytomegalovirus Disease Treatments Historic Market Size by Application (2016-2021) 5.2 Global Cytomegalovirus Disease Treatments Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cytomegalovirus Disease Treatments Market Size (2016-2027) 6.2 North America Cytomegalovirus Disease Treatments Market Size by Type 6.2.1 North America Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) 6.2.2 North America Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) 6.2.3 North America Cytomegalovirus Disease Treatments Market Size by Type (2016-2027) 6.3 North America Cytomegalovirus Disease Treatments Market Size by Application 6.3.1 North America Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) 6.3.2 North America Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) 6.3.3 North America Cytomegalovirus Disease Treatments Market Size by Application (2016-2027) 6.4 North America Cytomegalovirus Disease Treatments Market Size by Country 6.4.1 North America Cytomegalovirus Disease Treatments Market Size by Country (2016-2021) 6.4.2 North America Cytomegalovirus Disease Treatments Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Cytomegalovirus Disease Treatments Market Size (2016-2027) 7.2 Europe Cytomegalovirus Disease Treatments Market Size by Type 7.2.1 Europe Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) 7.2.2 Europe Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) 7.2.3 Europe Cytomegalovirus Disease Treatments Market Size by Type (2016-2027) 7.3 Europe Cytomegalovirus Disease Treatments Market Size by Application 7.3.1 Europe Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) 7.3.2 Europe Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) 7.3.3 Europe Cytomegalovirus Disease Treatments Market Size by Application (2016-2027) 7.4 Europe Cytomegalovirus Disease Treatments Market Size by Country 7.4.1 Europe Cytomegalovirus Disease Treatments Market Size by Country (2016-2021) 7.4.2 Europe Cytomegalovirus Disease Treatments Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Cytomegalovirus Disease Treatments Market Size (2016-2027) 8.2 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Type 8.2.1 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Type (2016-2027) 8.3 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Application 8.3.1 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Application (2016-2027) 8.4 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Region 8.4.1 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cytomegalovirus Disease Treatments Market Size (2016-2027) 9.2 Latin America Cytomegalovirus Disease Treatments Market Size by Type 9.2.1 Latin America Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) 9.2.2 Latin America Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) 9.2.3 Latin America Cytomegalovirus Disease Treatments Market Size by Type (2016-2027) 9.3 Latin America Cytomegalovirus Disease Treatments Market Size by Application 9.3.1 Latin America Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) 9.3.2 Latin America Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) 9.3.3 Latin America Cytomegalovirus Disease Treatments Market Size by Application (2016-2027) 9.4 Latin America Cytomegalovirus Disease Treatments Market Size by Country 9.4.1 Latin America Cytomegalovirus Disease Treatments Market Size by Country (2016-2021) 9.4.2 Latin America Cytomegalovirus Disease Treatments Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cytomegalovirus Disease Treatments Market Size (2016-2027) 10.2 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Type 10.2.1 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Type (2016-2027) 10.3 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Application 10.3.1 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Application (2016-2027) 10.4 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Country 10.4.1 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Cytomegalovirus Disease Treatments Introduction 11.1.4 Merck Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) 11.1.5 Merck Recent Development 11.2 Chimerix 11.2.1 Chimerix Company Details 11.2.2 Chimerix Business Overview 11.2.3 Chimerix Cytomegalovirus Disease Treatments Introduction 11.2.4 Chimerix Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) 11.2.5 Chimerix Recent Development 11.3 Abbott 11.3.1 Abbott Company Details 11.3.2 Abbott Business Overview 11.3.3 Abbott Cytomegalovirus Disease Treatments Introduction 11.3.4 Abbott Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) 11.3.5 Abbott Recent Development 11.4 Bio-Rad 11.4.1 Bio-Rad Company Details 11.4.2 Bio-Rad Business Overview 11.4.3 Bio-Rad Cytomegalovirus Disease Treatments Introduction 11.4.4 Bio-Rad Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) 11.4.5 Bio-Rad Recent Development 11.5 Roche 11.5.1 Roche Company Details 11.5.2 Roche Business Overview 11.5.3 Roche Cytomegalovirus Disease Treatments Introduction 11.5.4 Roche Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) 11.5.5 Roche Recent Development 11.6 Gilead Sciences 11.6.1 Gilead Sciences Company Details 11.6.2 Gilead Sciences Business Overview 11.6.3 Gilead Sciences Cytomegalovirus Disease Treatments Introduction 11.6.4 Gilead Sciences Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) 11.6.5 Gilead Sciences Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cytomegalovirus Disease Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Ganciclovir Table 3. Key Players of Valganciclovir Table 4. Key Players of Foscarnet Table 5. Key Players of Cidofovir Table 6. Key Players of Others Table 7. Global Cytomegalovirus Disease Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Cytomegalovirus Disease Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Cytomegalovirus Disease Treatments Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Cytomegalovirus Disease Treatments Market Share by Regions (2016-2021) Table 11. Global Cytomegalovirus Disease Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Cytomegalovirus Disease Treatments Market Share by Regions (2022-2027) Table 13. Cytomegalovirus Disease Treatments Market Trends Table 14. Cytomegalovirus Disease Treatments Market Drivers Table 15. Cytomegalovirus Disease Treatments Market Challenges Table 16. Cytomegalovirus Disease Treatments Market Restraints Table 17. Global Cytomegalovirus Disease Treatments Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Cytomegalovirus Disease Treatments Market Share by Players (2016-2021) Table 19. Global Top Cytomegalovirus Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Disease Treatments as of 2020) Table 20. Ranking of Global Top Cytomegalovirus Disease Treatments Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Cytomegalovirus Disease Treatments Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Cytomegalovirus Disease Treatments Product Solution and Service Table 24. Date of Enter into Cytomegalovirus Disease Treatments Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 27. Global Cytomegalovirus Disease Treatments Revenue Market Share by Type (2016-2021) Table 28. Global Cytomegalovirus Disease Treatments Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Cytomegalovirus Disease Treatments Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Cytomegalovirus Disease Treatments Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Cytomegalovirus Disease Treatments Revenue Market Share by Application (2016-2021) Table 32. Global Cytomegalovirus Disease Treatments Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Cytomegalovirus Disease Treatments Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 35. North America Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 37. North America Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Cytomegalovirus Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Cytomegalovirus Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Cytomegalovirus Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Cytomegalovirus Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Cytomegalovirus Disease Treatments Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Cytomegalovirus Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Cytomegalovirus Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Cytomegalovirus Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 64. Merck Company Details Table 65. Merck Business Overview Table 66. Merck Cytomegalovirus Disease Treatments Product Table 67. Merck Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) & (US$ Million) Table 68. Merck Recent Development Table 69. Chimerix Company Details Table 70. Chimerix Business Overview Table 71. Chimerix Cytomegalovirus Disease Treatments Product Table 72. Chimerix Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) & (US$ Million) Table 73. Chimerix Recent Development Table 74. Abbott Company Details Table 75. Abbott Business Overview Table 76. Abbott Cytomegalovirus Disease Treatments Product Table 77. Abbott Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) & (US$ Million) Table 78. Abbott Recent Development Table 79. Bio-Rad Company Details Table 80. Bio-Rad Business Overview Table 81. Bio-Rad Cytomegalovirus Disease Treatments Product Table 82. Bio-Rad Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) & (US$ Million) Table 83. Bio-Rad Recent Development Table 84. Roche Company Details Table 85. Roche Business Overview Table 86. Roche Cytomegalovirus Disease Treatments Product Table 87. Roche Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) & (US$ Million) Table 88. Roche Recent Development Table 89. Gilead Sciences Company Details Table 90. Gilead Sciences Business Overview Table 91. Gilead Sciences Cytomegalovirus Disease Treatments Product Table 92. Gilead Sciences Revenue in Cytomegalovirus Disease Treatments Business (2016-2021) & (US$ Million) Table 93. Gilead Sciences Recent Development Table 94. Research Programs/Design for This Report Table 95. Key Data Information from Secondary Sources Table 96. Key Data Information from Primary Sources List of Figures Figure 1. Global Cytomegalovirus Disease Treatments Market Share by Type: 2020 VS 2027 Figure 2. Ganciclovir Features Figure 3. Valganciclovir Features Figure 4. Foscarnet Features Figure 5. Cidofovir Features Figure 6. Others Features Figure 7. Global Cytomegalovirus Disease Treatments Market Share by Application: 2020 VS 2027 Figure 8. Stem Cell Transplantation Case Studies Figure 9. Organ Transplantation Case Studies Figure 10. Congenital CMV Infection Case Studies Figure 11. Others Case Studies Figure 12. Cytomegalovirus Disease Treatments Report Years Considered Figure 13. Global Cytomegalovirus Disease Treatments Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Cytomegalovirus Disease Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Cytomegalovirus Disease Treatments Market Share by Regions: 2020 VS 2027 Figure 16. Global Cytomegalovirus Disease Treatments Market Share by Regions (2022-2027) Figure 17. Global Cytomegalovirus Disease Treatments Market Share by Players in 2020 Figure 18. Global Top Cytomegalovirus Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Disease Treatments as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Cytomegalovirus Disease Treatments Revenue in 2020 Figure 20. Global Cytomegalovirus Disease Treatments Revenue Market Share by Type (2016-2021) Figure 21. Global Cytomegalovirus Disease Treatments Revenue Market Share by Type (2022-2027) Figure 22. North America Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Cytomegalovirus Disease Treatments Market Share by Type (2016-2027) Figure 24. North America Cytomegalovirus Disease Treatments Market Share by Application (2016-2027) Figure 25. North America Cytomegalovirus Disease Treatments Market Share by Country (2016-2027) Figure 26. United States Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Cytomegalovirus Disease Treatments Market Share by Type (2016-2027) Figure 30. Europe Cytomegalovirus Disease Treatments Market Share by Application (2016-2027) Figure 31. Europe Cytomegalovirus Disease Treatments Market Share by Country (2016-2027) Figure 32. Germany Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Cytomegalovirus Disease Treatments Market Share by Type (2016-2027) Figure 40. Asia-Pacific Cytomegalovirus Disease Treatments Market Share by Application (2016-2027) Figure 41. Asia-Pacific Cytomegalovirus Disease Treatments Market Share by Region (2016-2027) Figure 42. China Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Cytomegalovirus Disease Treatments Market Share by Type (2016-2027) Figure 50. Latin America Cytomegalovirus Disease Treatments Market Share by Application (2016-2027) Figure 51. Latin America Cytomegalovirus Disease Treatments Market Share by Country (2016-2027) Figure 52. Mexico Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Cytomegalovirus Disease Treatments Market Share by Type (2016-2027) Figure 56. Middle East & Africa Cytomegalovirus Disease Treatments Market Share by Application (2016-2027) Figure 57. Middle East & Africa Cytomegalovirus Disease Treatments Market Share by Country (2016-2027) Figure 58. Turkey Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Cytomegalovirus Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Merck Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2016-2021) Figure 62. Chimerix Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2016-2021) Figure 63. Abbott Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2016-2021) Figure 64. Bio-Rad Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2016-2021) Figure 65. Roche Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2016-2021) Figure 66. Gilead Sciences Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Merck Chimerix Abbott Bio-Rad Roche Gilead Sciences